Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Rosa Ruiz-Valderas"'
Autor:
Antonio Rivero-Juarez, Luis F López-Cortés, Angela Camacho, Almudena Torres-Cornejo, Ana Gordon, Rosa Ruiz-Valderas, Julian Torre-Cisneros, Juan A Pineda, Pompeyo Viciana, Antonio Rivero
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99468 (2014)
Optimizing HCV genotype 1 therapy in terms of response prediction and tailoring treatment is undoubtedly the cornerstone of treating HIV co-infected patients in clinical practice. Accordingly, our aim was to analyze the predictive value of HCV viral
Externí odkaz:
https://doaj.org/article/a7e417e1748149ba8f715d75ea3d781a
Autor:
Luis F López-Cortés, Rosa Ruiz-Valderas, Luis Jimenez-Jimenez, María F González-Escribano, Almudena Torres-Cornejo, Rosario Mata, Antonio Rivero, Juan A Pineda, Manuel Marquez-Solero, Pompeyo Viciana, Grupo para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e28115 (2012)
BACKGROUND:Data on which to base definitive recommendations on the doses and duration of therapy for genotype 3 HCV/HIV-coinfected patients are scarce. We evaluated the efficacy of a lower peginterferon-α 2a dose and a shorter duration of therapy th
Externí odkaz:
https://doaj.org/article/16ba3d97550b4e0f85774a45f664c0a4
Autor:
Antonio Rivero-Juárez, Luis F Lopez-Cortes, Angela Camacho, Almudena Torres-Cornejo, Juan A Pineda, Manuel Marquez-Solero, Antonio Caruz, Rosa Ruiz-Valderas, Julian Torre-Cisneros, Alicia Gutierrez-Valencia, Antonio Rivero
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48959 (2012)
The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-α2a/RBV therapies on HCV viral decline in HIV/HCV genotype 3 co-infected patients during the first weeks of treatment.Plasma HCV viral decline was analyzed bet
Externí odkaz:
https://doaj.org/article/6082669abc7642199dd8aca9af1b5860
Autor:
Luis F. López-Cortés, Rosa Ruiz-Valderas, Almudena Torres-Cornejo, Omar J. BenMarzouk-Hidalgo, Alicia Gutierrez-Valencia, Pompeyo Viciana
Publikováno v:
HIV Medicine. 16:57-61
Objective To assess the changes on the HIV protease gene in plasma and peripheral blood mononuclear cell (PBMC) compartments during viral replication episodes in patients on boosted-darunavir monotherapy (mtDRV/rtv). Methods A prospective study was c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5ab05a943e08d1106592dc1100ffb7b
https://doi.org/10.1111/hiv.12170
https://doi.org/10.1111/hiv.12170
Autor:
Nuria Espinosa, Juan R. Castillo-Ferrando, Alicia Gutierrez-Valencia, Pompeyo Viciana, Rosa Ruiz-Valderas, Almudena Torres-Cornejo, Luis F. López-Cortés
Publikováno v:
Clinical Infectious Diseases. 58:268-273
Background Detrimental bidirectional pharmacokinetic interactions have been observed when telaprevir (TVR) and ritonavir (RTV)-boosted human immunodeficiency virus (HIV) protease inhibitors are coadministered in healthy volunteers. Our aim was to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f90f669a6c1f308c9446c3d8925d45
https://doi.org/10.1093/cid/cit693
https://doi.org/10.1093/cid/cit693
Autor:
Alicia Gutierrez-Valencia, Rosa Ruiz-Valderas, Luis F. López-Cortés, Elena Sánchez-Rivas, Almudena Torres-Cornejo, Amparo Lluch, Omar J. BenMarzouk-Hidalgo, Pompeyo Viciana
Publikováno v:
Antimicrobial Agents and Chemotherapy. 57:3746-3751
There is significant intra- and intersubject variability in lopinavir (LPV) plasma concentrations after standard dosing; thus, this prospective study was conducted to determine whether low plasma LPV concentrations could be associated with virologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3095b66c5ccef3c25c3b0de7a6924114
https://doi.org/10.1128/aac.00315-13
https://doi.org/10.1128/aac.00315-13
Autor:
Almudena Torres-Cornejo, Rosa Ruiz-Valderas, L. Jimenez-Jimenez, Cristina Abad-Molina, Luis F. López-Cortés, Pompeyo Viciana, Alicia Gutierrez-Valencia
Publikováno v:
Journal of Viral Hepatitis. 21:178-188
Summary Studies on the association between the peginterferon-α and ribavirin levels and sustained virological response (SVR) have shown yielded conflicting results, but most of them were performed before the influence of IL28B polymorphisms was know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30919623540a32ab07361e1ee033462b
https://doi.org/10.1111/jvh.12128
https://doi.org/10.1111/jvh.12128
Autor:
C. Pichardo, Rafael López-Rojas, Jerónimo Pachón, Juan Domínguez-Herrera, Rosa Ruiz-Valderas, Fernando Docobo-Pérez, José Antonio Lepe
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:613-617
Staphylococcus epidermidis is a frequent cause of device-associated infections. In this study, we compared the efficacy of daptomycin versus vancomycin against biofilm-producing methicillin-resistant S. epidermidis (MRSE) strains in a murine model of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94cb26b6469a2bf509a8d87e57b80555
https://doi.org/10.1128/aac.05606-11
https://doi.org/10.1128/aac.05606-11
Autor:
Ana Marin-Niebla, Fernando Lozano, Antonio Vergara de Campos, Luis F. López-Cortés, Eva M León, Rebeca Valiente, Rosa Ruiz-Valderas, Josefa Ruiz-Morales, Manuel Márquez-Solero
Publikováno v:
Journal of Antimicrobial Chemotherapy. 58:1017-1023
Objectives: To assess the safety and efficacy of efavirenz 800 mg daily in HIV-infected patients with tuberculosis receiving a rifampicin-containing regimen and to analyse whether a relationship exists between efavirenz C min and its virological effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fc6475c8413df901e8d2f64fadce72c
https://doi.org/10.1093/jac/dkl357
https://doi.org/10.1093/jac/dkl357
Autor:
Jerónimo Pachón, Eva León-Jimenez, Aristides Alarcón-González, Yolanda López-Púa, Rosa Ruiz-Valderas, Luis F. López-Cortés, Pompeyo Viciana, Jesús Gómez-Mateos, Marı́a Sarasa-Nacenta
Publikováno v:
Clinical Pharmacokinetics. 41:681-690
To evaluate the pharmacokinetic interactions between efavirenz and rifampicin (rifampin) in patients with HIV infection and tuberculosis.Nonblind, randomised, pharmacokinetic study.24 patients (21 male, 3 female; mean age 37 years) with HIV infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f035b5a37cee4ff9bdb797779396d67f
https://doi.org/10.2165/00003088-200241090-00004
https://doi.org/10.2165/00003088-200241090-00004